ANI Pharmaceuticals, Inc. (BST:BSFA)

Market Cap	1.37B +21.1%
Revenue (ttm)	752.36M +43.8%
Net Income	65.73M
EPS	2.83
Shares Out	n/a
PE Ratio	20.80
Forward PE	8.68
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	7
Open	63.50
Previous Close	64.50
Day's Range	63.50 - 65.00
52-Week Range	49.60 - 84.00
Beta	n/a
RSI	44.16
Earnings Date	Feb 27, 2026

About ANI Pharmaceuticals

ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally. The company provides injectables, softgel capsules, and Cortrophin gel, as well as ILUVIEN and YUTIQ products. It also manufactures oral solid dose products, semi-solids, liquids, topicals, controlled substances, and potent products. It markets, sells, and distributes its products through wholesalers, retail market chains, distributors and specialty pharmacies, group pu...

• Industry: Pharmaceutical Preparations
• Founded: 2001
• Employees: 897
• Stock Exchange: Stuttgart Stock Exchange
• Ticker Symbol: BSFA

Financial Performance

Financial numbers in USD